Kiniksa Pharmaceuticals (KNSA)
(Delayed Data from NSDQ)
$19.53 USD
-0.66 (-3.27%)
Updated May 10, 2024 04:00 PM ET
After-Market: $19.56 +0.03 (0.15%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/23/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | -78.57% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.10 |
Next Year | 0.39 |
EPS (TTM) | -0.43 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 87.84M | 99.65M | 380.84M | 495.29M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 88.60M | 99.99M | 384.57M | 501.90M |
Low Estimate | 87.07M | 99.30M | 377.10M | 488.67M |
Year ago Sales | 71.47M | 67.05M | 270.26M | 380.84M |
Year over Year Growth Est. | 22.90% | 48.61% | 40.91% | 30.05% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.02 | -0.10 | 0.39 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.06 | -0.02 | -0.32 | 0.24 |
High Estimate | -0.06 | -0.02 | 0.45 | 1.15 |
Low Estimate | -0.12 | -0.02 | -0.43 | -0.21 |
Year ago EPS | -0.02 | -0.20 | -0.34 | -0.10 |
Year over Year Growth Est. | -350.00% | 90.00% | 70.59% | 493.33% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.09 | -0.02 | -0.10 | 0.39 |
7 Days Ago | -0.09 | -0.02 | -0.10 | 0.39 |
30 Days Ago | -0.11 | -0.07 | -0.06 | -0.45 |
60 Days Ago | -0.11 | -0.07 | -0.05 | -0.43 |
90 Days Ago | -0.15 | -0.11 | -0.11 | -0.18 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.02 | -0.10 | 0.39 |
Zacks Consensus Estimate | -0.09 | -0.02 | -0.10 | 0.39 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | 0.04 | -0.20 | -0.02 | NA |
Estimate | -0.14 | -0.11 | -0.18 | -0.16 | NA |
Difference | -0.11 | 0.15 | -0.02 | 0.14 | 0.04 |
Surprise | -78.57% | 136.36% | -11.11% | 87.50% | 33.55% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more